[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20055750L - Nye kjemiske forbindelser - Google Patents

Nye kjemiske forbindelser

Info

Publication number
NO20055750L
NO20055750L NO20055750A NO20055750A NO20055750L NO 20055750 L NO20055750 L NO 20055750L NO 20055750 A NO20055750 A NO 20055750A NO 20055750 A NO20055750 A NO 20055750A NO 20055750 L NO20055750 L NO 20055750L
Authority
NO
Norway
Prior art keywords
chemical compounds
new chemical
compounds
preparing
useful
Prior art date
Application number
NO20055750A
Other languages
English (en)
Other versions
NO20055750D0 (no
Inventor
Kristjan Gudmundsson
Sharon Davis Boggs
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20055750D0 publication Critical patent/NO20055750D0/no
Publication of NO20055750L publication Critical patent/NO20055750L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Foreliggende oppfinnelse angår nye forbindelser med formel (1) som er anvendelige ved behandling av humane papillomavirus, og også metodene for fremstilling av og anvendelse av slike forbindelser.
NO20055750A 2003-06-12 2005-12-05 Nye kjemiske forbindelser NO20055750L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47797203P 2003-06-12 2003-06-12
US49778703P 2003-08-26 2003-08-26
PCT/US2004/018180 WO2005005386A1 (en) 2003-06-12 2004-06-07 Tetrahydrocarbazole derivatives and their pharmaceutical use

Publications (2)

Publication Number Publication Date
NO20055750D0 NO20055750D0 (no) 2005-12-05
NO20055750L true NO20055750L (no) 2006-01-06

Family

ID=34068099

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055750A NO20055750L (no) 2003-06-12 2005-12-05 Nye kjemiske forbindelser

Country Status (15)

Country Link
US (1) US7419997B2 (no)
EP (1) EP1646610B1 (no)
JP (1) JP2007500750A (no)
KR (1) KR20060017544A (no)
AU (1) AU2004256052A1 (no)
BR (1) BRPI0411245A (no)
CA (1) CA2528336A1 (no)
CO (1) CO5660264A2 (no)
DE (1) DE602004022169D1 (no)
ES (1) ES2327416T3 (no)
IL (1) IL172087A0 (no)
MA (1) MA27879A1 (no)
NO (1) NO20055750L (no)
RU (1) RU2005138126A (no)
WO (1) WO2005005386A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1678137A1 (en) * 2003-10-15 2006-07-12 Chiron Corporation Compositions and methods for viral inhibition
US7767689B2 (en) 2004-03-15 2010-08-03 Ptc Therapeutics, Inc. Carboline derivatives useful in the treatment of cancer
UA92317C2 (ru) 2004-03-15 2010-10-25 Пи-Ти-Си ТЕРАПЬЮТИКС, ИНК. Производные карболина, пригодные для ингибирования развития кровеносных сосудов
US8076352B2 (en) 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Administration of carboline derivatives useful in the treatment of cancer and other diseases
US8076353B2 (en) 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Inhibition of VEGF translation
WO2006012310A2 (en) * 2004-06-25 2006-02-02 Genzyme Corporation Carbazole derivatives for treating polycystic kidney disease
WO2006118607A2 (en) * 2004-11-22 2006-11-09 Smithkline Beecham Corporation Hcv inhibitors with carbazole structure
MX2007006179A (es) * 2004-11-23 2007-06-20 Ptc Therapeutics Inc Tetrahidrocarbazoles como agentes activos para inhibir la produccion del factor de crecimiento endotelial vascular por control de la traduccion.
US11458121B2 (en) * 2017-06-26 2022-10-04 Rutgers, The State University Of New Jersey Therapeutic compounds and methods to treat infection
US10882821B1 (en) 2017-09-26 2021-01-05 The Board Of Trustees Of The Leland Stanford Junior University Enantiomeric compound for the reduction of the deleterious activity of extended nucleotide repeat containing genes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9008108D0 (en) 1990-04-10 1990-06-06 Bayer Ag Cycloalkano(b)dihydroindoles and-indolesulphonamides substituted by heterocycles
US5100891A (en) * 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
GB0015904D0 (en) 2000-06-28 2000-08-23 Hoffmann La Roche Inhibitors of HPV E1 helicase enzyme
DE10164564B4 (de) * 2001-12-14 2007-05-16 Zentaris Gmbh Tetrahydrocarbazolderivate als Liganden für G-Protein gekoppelte Rezeptoren (GPCR)

Also Published As

Publication number Publication date
CA2528336A1 (en) 2005-01-20
US20060148857A1 (en) 2006-07-06
US7419997B2 (en) 2008-09-02
CO5660264A2 (es) 2006-07-31
IL172087A0 (en) 2009-02-11
KR20060017544A (ko) 2006-02-23
EP1646610A1 (en) 2006-04-19
NO20055750D0 (no) 2005-12-05
WO2005005386A1 (en) 2005-01-20
JP2007500750A (ja) 2007-01-18
MA27879A1 (fr) 2006-05-02
RU2005138126A (ru) 2006-07-27
ES2327416T3 (es) 2009-10-29
AU2004256052A1 (en) 2005-01-20
BRPI0411245A (pt) 2006-07-18
DE602004022169D1 (de) 2009-09-03
EP1646610B1 (en) 2009-07-22

Similar Documents

Publication Publication Date Title
NO20083411L (no) Indaneddiksyrederivater og deres anvendelse som farmasoytiske midler, intermediater og fremgangsmater for fremstilling
NO20063479L (no) Fosfonater, monofosfonamidater og bis-fosfonamidater for behandling av virussykdommer
ATE368031T1 (de) Neue gamma secretase inhibitoren
NO20060230L (no) Nye aminobenzofenonforbindelser
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
WO2005013892A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
MXPA05012323A (es) Sulfonamidas ciclicas para la inhibicion de gama-secretasa.
NO20055731L (no) Cannabinoide reseptorligander og deres anvendelse
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
ATE396174T1 (de) Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
NO20076638L (no) Nye 8-sulfonylamino-3-aminosubstituerte kroman- eller tetrahydronaftalenderivater som modulerer 5HT6-reseptoren
NO20060314L (no) Nicotinamid-derivater anvendbare som PDE4-inhibitorer
NO20063576L (no) 1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
SE0301368D0 (sv) Chemical compounds
NO20055977L (no) Nye benzimidazolderivater
NO20055741D0 (no) Nye kjemiske forbindelser
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
NO20060718L (no) Substituerte tiofoner og deres anvendelse
NO20054361L (no) Benzensylfonamidderivater, fremgangsmate for fremstilling og anvendelse derav for behandlig av smerte
SE0300850D0 (sv) Chemical compounds
DE602004031410D1 (de) Inden derivate als pharmazeutika
NO20055750L (no) Nye kjemiske forbindelser
DE60325377D1 (de) Motilidverbindungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application